Can chiglitazar help reduce liver fat in MASLD patients with high triglycerides?
Chiglitazar is a drug that activates multiple PPAR receptors, which help regulate fat and sugar metabolism. For MASLD patients with high triglycerides (hypertriglyceridemia) and insulin resistance, a recent clinical trial shows that chiglitazar can significantly lower liver fat content. This offers a potential treatment option for a group that often has limited therapies.
What the research says
A phase II, randomized, double-blind, placebo-controlled study tested chiglitazar in 104 MASLD patients with hypertriglyceridemia and insulin resistance 69. Patients received either 48 mg, 64 mg of chiglitazar, or placebo daily for 18 weeks. The main goal was to measure the change in liver fat using MRI-PDFF, a precise imaging technique 69.
Results showed that chiglitazar reduced liver fat significantly. The 48 mg group had a 28.1% decrease, and the 64 mg group had a 39.5% decrease, compared to only a 3.2% decrease with placebo 69. The differences from placebo were statistically significant (p <0.05 for 48 mg, p <0.001 for 64 mg) 69.
Beyond liver fat, chiglitazar also improved liver enzyme levels (ALT, AST, gamma-GT), markers of liver fibrosis, blood lipid levels, and insulin resistance 69. These benefits suggest that chiglitazar may address multiple aspects of MASLD, not just fat accumulation.
A separate review of triglyceride-lowering therapies notes that reducing triglycerides can help lower liver fat in MASLD, and chiglitazar's effects on lipids fit this strategy 4. However, the chiglitazar trial was a phase II study with a relatively small number of patients and short duration (18 weeks) 69. Larger and longer studies are needed to confirm its long-term safety and effectiveness.
What to ask your doctor
- Is chiglitazar available for my condition, and am I a candidate given my triglyceride and insulin resistance levels?
- What are the potential side effects of chiglitazar, and how does it compare to other triglyceride-lowering treatments?
- Should I consider participating in a clinical trial for chiglitazar or similar new therapies?
- How will we monitor my liver fat and liver health if I start chiglitazar?
- Can chiglitazar be used alongside my current medications for diabetes or high cholesterol?
This question is drawn from common patient questions about Gastroenterology and answered using cited medical research. We do not provide individualized advice.